Literature DB >> 24994550

MRI-guided laser interstitial thermal therapy in neuro-oncology: a review of its current clinical applications.

Gazanfar Rahmathulla1, Pablo F Recinos, Kambiz Kamian, Alireza M Mohammadi, Manmeet S Ahluwalia, Gene H Barnett.   

Abstract

Magnetic resonance imaging-guided laser interstitial thermal therapy (LITT) is a minimally invasive treatment modality with recent increasing use to ablate brain tumors. When originally introduced in the late 1980s, the inability to precisely monitor and control the thermal ablation limited the adoption of LITT in neuro-oncology. Popularized as a means of destroying malignant hepatic and renal metastatic lesions percutaneously, its selective thermal tumor destruction and preservation of adjacent normal tissues have since been optimized for use in neuro-oncology. The progress made in real-time thermal imaging with MRI, laser probe design, and computer algorithms predictive of tissue kill has led to the resurgence of interest in LITT as a means to ablate brain tumors. Current LITT systems offer a surgical option for some inoperable brain tumors. We discuss the origins, principles, current indications, and future directions of MRI-guided LITT in neuro-oncology.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24994550     DOI: 10.1159/000362817

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  20 in total

1.  Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.

Authors:  Aditya Iyer; Casey H Halpern; Gerald A Grant; Sayantan Deb; Gordon H Li
Journal:  Cureus       Date:  2016-12-07

2.  Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy.

Authors:  T P Easwaran; A Lion; A O Vortmeyer; K Kingery; McDonald Bc; J S Raskin
Journal:  Childs Nerv Syst       Date:  2020-01-11       Impact factor: 1.475

3.  Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy.

Authors:  Vivek B Beechar; Sujit S Prabhu; Dhiego Bastos; Jeffrey S Weinberg; R Jason Stafford; David Fuentes; Kenneth R Hess; Ganesh Rao
Journal:  J Neurooncol       Date:  2017-12-04       Impact factor: 4.130

4.  Laser Interstitial Thermal Therapy.

Authors:  Bhuvic Patel; Albert H Kim
Journal:  Mo Med       Date:  2020 Jan-Feb

5.  Image-guided resection of glioblastoma in eloquent brain areas facilitated by laser surface thermal therapy: clinical outcomes and long-term results.

Authors:  Artem Rozumenko; Valentyn Kliuchka; Volodymir Rozumenko; Vera Semenova; Sergii Kolesnyk; Zoja Fedorenko
Journal:  Neurosurg Rev       Date:  2018-01-22       Impact factor: 3.042

6.  Intraoperative real-time MRI-guided stereotactic biopsy followed by laser thermal ablation for progressive brain metastases after radiosurgery.

Authors:  Roy G Torcuator; M Maher Hulou; Vamsidhar Chavakula; Ferenc A Jolesz; Alexandra J Golby
Journal:  J Clin Neurosci       Date:  2015-11-16       Impact factor: 1.961

Review 7.  The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier.

Authors:  Bhuvic Patel; Peter H Yang; Albert H Kim
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 8.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 9.  In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors.

Authors:  Joshua D Frenster; Shivang Desai; Dimitris G Placantonakis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 10.  Neurosurgical management of brain metastases.

Authors:  Sherise D Ferguson; Kathryn M Wagner; Sujit S Prabhu; Mary F McAleer; Ian E McCutcheon; Raymond Sawaya
Journal:  Clin Exp Metastasis       Date:  2017-09-30       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.